The tech and innovation sector continues to attract large investments, with several high-growth startups announcing major funding rounds this past week. Here are the five top startup funding deals announced during the week ending May 18th, 2025, based on data curated from the Intellizence Startup Funding Dataset.
Pathos
Funding Amount: $365 Million
Funding Round: Series D
Industry: Biotechnology
Country: United States
Pathos AI, a leading AI-driven biotech company, raised $365 million in Series D financing, bringing its post-money valuation to approximately $1.6 billion. The company had raised $62 million Series C funding round\ just seven months ago, bringing the company’s total capital raised to around $467 million. The company will use the funds to advance Pathos AI’s clinical-stage pipeline and to further develop its proprietary AI platform, PathOS. This platform is designed to integrate multimodal data—including clinical, molecular, and imaging information—to enhance clinical asset selection, optimize trial designs, and identify novel biomarkers in oncology.
Addepar
Funding Amount: $230 Million
Funding Round: Series G
Industry: Fintech
Country: United States
Addepar, a US-based data platform serving the wealth and investment sector, has secured a $230 million Series G funding round, pushing the firm’s valuation to $3.25 billion. The round was co-led by Vitruvian Partners and WestCap, with participation from existing investors 8VC and Valor Equity Partners, as well as new investor EDBI, the investment arm of Singapore’s Economic Development Board. The funds are primarily allocated to a tender offer, providing liquidity to employees and early shareholders. Additionally, the funding amount will support the company’s global expansion and continued investment in product development, including enhancements in artificial intelligence and alternative investment tools.
Stord
Funding Amount: $200 Million
Funding Round: Series E
Industry: e-Commerce
Country: United States
Stord has raised over $200 million in Series E equity funding with support via growth debt financing at a valuation of $1.5 billion. The equity funding was led by Strike Capital, with additional support via growth debt facility from Silicon Valley Bank (SVB) and ORIX USA. New investors, Baillie Gifford, NewView Capital, G Squared, and Georgia Tech Foundation, joined the round and existing investors, Kleiner Perkins, Franklin Templeton, Founders Fund, Bond, Sozo, 137, and Lux, also participated.
Azafaros
Funding Amount: $147 Million
Funding Round: Series B
Industry: Biotechnology
Country: Netherlands
Dutch biotech Azafaros gains €132 million ($147 million) Series B to fund phase 3 trials of brain-penetrant drug. The funding will support two pivotal Phase 3 clinical trials of its lead candidate, nizubaglustat, targeting rare lysosomal storage disorders (LSDs) with severe neurological involvement, including Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses. The round was led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group, and existing investors Forbion Ventures, Schroders Capital, and BioGeneration Ventures (BGV).
Stash
Funding Amount: $146 Million
Funding Round: Series H
Industry: Fintech
Country: United States
Stash, a U.S.-based fintech platform helping millions build financial futures, has secured $146 million in an oversubscribed new Series H funding. The round was led by Goodwater Capital, with participation from existing investors including Union Square Ventures, StepStone Group, Serengeti, the University of Illinois Foundation, and funds advised by T. Rowe Price Investment Management. This capital will accelerate Stash’s mission to make expert financial guidance accessible to everyone and deepen its investment in artificial intelligence (AI) to transform its financial guidance capabilities.
Identify Emerging Opportunities & Risks